Treprostinil | Interleukin Related interleukin-related.com

Product Name :
Treprostinil

Search keywords :
PAH

drugId :
null

Target Vo:
Prostanoid IP receptor

Target Vo Short Name :
PTGIR

Moa_Name:
Prostanoid IP receptor agonists

First Approval Country :
United States

First Approval Date Filter:
2002

Origin Company_Name :
United Therapeutics Corp

Active Company_Name :
Aop Orphan Pharmaceuticals Ag

Active Indication_Name:
Lung Diseases, Interstitial

In Active Indication_Name:
Respiratory Distress Syndrome, Adult

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Insulin Antibody
GSDMD Antibody
c-Myc Antibody: c-Myc Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to c-Myc. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts